The relationship of cognitive performance to concurrent symptoms cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study

摘要

PurposeCognitive dysfunction in women with breast cancer continues to be an area of intense research interest. The prevalence, severity, timing, and cognitive domains that are most affected, as well as the contribution of cancer and its treatments to cognition, remain unresolved. Thus, longitudinal studies are needed that examine cognitive function during different stages of breast cancer treatment and survivorship. This longitudinal trial followed women with early-stage breast cancer, prior to chemotherapy through 2 years survivorship.